Skip to content

阿泰生命科学

US · ATAI #2575 按市值排名 上市于 2021
0.00 0.00 0.00%
实时 - 追踪5344个代码 - 心跳于256秒前 · 2026-10-16 09:30

最新新闻

  • 公司公告
    ATAI Life Sciences | 4: Statement of changes in beneficial ownership of securities-10% Owner Apeiron Investment Group Ltd.
    SEC · 2025/3/25
  • H.C. Wainwright Maintains AtaiBeckley(ATAI.US) With Hold Rating, Maintains Target Price $7.5
    \u5e02\u573a\u8d44\u8baf · 2026/8/21
  • U.S. Stocks Move Sharply | Atai Life Sciences plc (ATAI.US) Surges Over 30% at Open Following Eli Lilly and Co's Acquisition Offer of Up to $3.8 Billion
    Zhitong Finance · 2026/7/16
  • Deutsche Bank Downgrades AtaiBeckley(ATAI.US) to Hold Rating, Cuts Target Price to $8
    \u5e02\u573a\u8d44\u8baf · 2026/8/12
  • 评级变动
    H.C. Wainwright Downgrades AtaiBeckley(ATAI.US) to Hold Rating, Cuts Target Price to $7.5
    \u5e02\u573a\u8d44\u8baf · 2026/7/20
  • 评级变动
    A Quick Look at Today's Ratings for AtaiBeckley(ATAI.US), With a Forecast Between $7.5 to $8
    \u5e02\u573a\u8d44\u8baf · 2026/7/17
  • 公司公告
    ATAI Life Sciences | 4: Statement of changes in beneficial ownership of securities-10% Owner Apeiron Investment Group Ltd.
    SEC · 2025/10/3
  • 公司公告
    ATAI Life Sciences | 4: Statement of changes in beneficial ownership of securities-10% Owner Apeiron Investment Group Ltd.
    SEC · 2025/8/19
  • Analysts' Opinions Are Mixed on These Healthcare Stocks: Atai Beckley N.V. (ATAI), InspireMD (NSPR) and Silexion Therapeutics (SLXN)
    TipRanks · 2026/8/20
  • 评级变动
    Berenberg Bank Sticks to Their Buy Rating for Atai Beckley N.V. (ATAI)
    TipRanks · 2026/7/18
  • 公司公告
    AtaiBeckley: AtaiBeckley Inc. - Anticipated Cash Settlement Option Symbol: ATAI
    OCC · 2026/8/12
  • 公司公告
    AtaiBeckley: AtaiBeckley Inc. - Cash Settlement/Acceleration of Expirations Option Symbol: ATAI
    OCC · 2026/9/11
  • 评级变动
    Analysts Offer Insights on Healthcare Companies: Genmab (GMAB), Definitive Healthcare Corp (DH) and Atai Beckley N.V. (ATAI)
    TipRanks · 2026/8/12
  • 评级变动
    Maxim Group Maintains AtaiBeckley(ATAI.US) With Hold Rating
    \u5e02\u573a\u8d44\u8baf · 2026/7/18
  • 评级变动
    Berenberg Bank Downgrades AtaiBeckley(ATAI.US) to Hold Rating, Cuts Target Price to $7.45
    \u5e02\u573a\u8d44\u8baf · 2026/7/20
  • 评级变动
    Berenberg Bank Maintains AtaiBeckley(ATAI.US) With Buy Rating, Maintains Target Price $14
    \u5e02\u573a\u8d44\u8baf · 2026/7/18
  • 评级变动
    Oppenheimer Downgrades AtaiBeckley(ATAI.US) to Hold Rating
    \u5e02\u573a\u8d44\u8baf · 2026/8/18
  • 评级变动
    TD Cowen Downgrades AtaiBeckley(ATAI.US) to Hold Rating
    \u5e02\u573a\u8d44\u8baf · 2026/7/18
  • 评级变动
    Jefferies Maintains AtaiBeckley(ATAI.US) With Hold Rating, Maintains Target Price $7.5
    \u5e02\u573a\u8d44\u8baf · 2026/7/17
  • News On AtaiBeckley Inc. (ATAI) Now Under LLY
    Dow Jones · 2026/9/12

新闻标题为自动聚合内容,未经我们团队独立核实或编辑。

报价时间 2026-10-16 09:30:00 · 仅供参考,不构成投资建议,也未考虑您的具体情况。

阿泰生命科学 讨论区 0 条评论

发表评论